← Back to Search

Cannabinoid

CBD/CBN for Osteoarthritis

Phase 2
Waitlist Available
Led By Debra Kimless, M.D.
Research Sponsored by Pure Green
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 28 days
Awards & highlights

Study Summary

This study is evaluating whether a new pain reliever is better than a placebo.

Eligible Conditions
  • Osteoarthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~28 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 28 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain as assessed by Numerical Pain Rating Scale (NPRS)
Knee
Secondary outcome measures
Incidence of treatment-related adverse events as assessed by CTCAE v4.0.

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: CBD/THCExperimental Treatment1 Intervention
Participants will receive a 28-day supply of CBD/THC sublingual tablets to be taken 3 times a day for 28 days.
Group II: CBD/CBNExperimental Treatment1 Intervention
Participants will receive a 28-day supply of CBD/CBN sublingual tablets to be taken 3 times a day for 28 days.
Group III: PlaceboPlacebo Group1 Intervention
A placebo sublingual tablet to be taken three times a day for 28 days
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CBD/THC
2019
Completed Phase 2
~10

Find a Location

Who is running the clinical trial?

Pure GreenLead Sponsor
5 Previous Clinical Trials
158 Total Patients Enrolled
1 Trials studying Osteoarthritis
30 Patients Enrolled for Osteoarthritis
Debra Kimless, M.D.Principal InvestigatorPure Green Pharmaceuticals
4 Previous Clinical Trials
142 Total Patients Enrolled
1 Trials studying Osteoarthritis
30 Patients Enrolled for Osteoarthritis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Clinics in Geriatric MedicineJournal
Epidemiology of Osteoarthritis
Zhang, Yuqing, and Joanne M. Jordan. 2010. “Epidemiology of Osteoarthritis”. Clinics in Geriatric Medicine. Elsevier BV. doi:10.1016/j.cger.2010.03.001.
Journal of Sport RehabilitationJournal
Responsiveness of the Numeric Pain Rating Scale in Patients with Shoulder Pain and the Effect of Surgical Status
Michener, Lori A., Alison R. Snyder, and Brian G. Leggin. 2011. “Responsiveness of the Numeric Pain Rating Scale in Patients with Shoulder Pain and the Effect of Surgical Status”. Journal of Sport Rehabilitation. Human Kinetics. doi:10.1123/jsr.20.1.115.
PainJournal
Clinical Importance of Changes in Chronic Pain Intensity Measured on an 11-point Numerical Pain Rating Scale
Farrar, John T., James P. Young, Linda LaMoreaux, John L. Werth, and Michael R. Poole. 2001. “Clinical Importance of Changes in Chronic Pain Intensity Measured on an 11-point Numerical Pain Rating Scale”. Pain. Ovid Technologies (Wolters Kluwer Health). doi:10.1016/s0304-3959(01)00349-9.
MMWR. Morbidity and Mortality Weekly ReportJournal
Increases in Drug and Opioid-involved Overdose Deaths — United States, 2010–2015
Rudd, Rose A., Puja Seth, Felicita David, and Lawrence Scholl. 2016. “Increases in Drug and Opioid-involved Overdose Deaths — United States, 2010–2015”. MMWR. Morbidity and Mortality Weekly Report. Centers for Disease Control MMWR Office. doi:10.15585/mmwr.mm655051e1.
~18 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top